Riccardo Lobefaro

Fasting-mimicking diet blocks triple-negative breast cancer and cancer stem cell escape

Giulia Salvadori, Federica Zanardi, Fabio Iannelli et al. · Cell Metabolism · 2021 · 160 citations · Full text

Medicine, Cancer Biology, Oncology +17

The Pan-Immune-Inflammation-Value Predicts the Survival of Patients with Human Epidermal Growth Factor Receptor 2 (HER2)—Positive Advanced Breast Cancer Treated with First-Line Taxane-Trastuzumab-Pertuzumab

Francesca Ligorio, Giovanni Fucà, Emma Zattarin et al. · Cancers · 2021 · 107 citations · Full text

Medicine, Immunology, Oncology +17

Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: A sub-analysis of the NCT03340935 trial

Francesca Ligorio, Giovanni Fucà, Leonardo Provenzano et al. · European Journal of Cancer · 2022 · 68 citations

Agriculture, Nutritional Sciences, Oncology +16

Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program

Arsela Prelaj, Achille Bottiglieri, Claudia Proto et al. · European Journal of Cancer · 2021 · 58 citations

Medicine, Genetics, Molecular Genetics +16

Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations

Mariona Riudavets, Édouard Auclin, Miguel Mosteiro et al. · European Journal of Cancer · 2022 · 53 citations · Full text

Medicine, Molecular Genetics, Oncology +13